Randox Toxicology are attending the Midwest Association for Toxicology and Therapeutic Drug Monitoring (MATT) annual meeting, April 14th - 15th, 2016.
Mark Vandervest from the Michigan State Police is presenting the 'Validation of the Randox DUID Biochip Array Technology for Detection and Quantitation of Drugs on a Randox Evidence'.
DUID Biochip is a new off the shelf product offering a large cross-reactivity profiling with extensive specificity of over 240 analytes. Following recommendation from the National Safety Council's Alcohol, Drugs and Impairment Division to test Tier I ans Tier II drugs. Tier I provides strong evidence of impairment, testing the most prevalent drugs in the US driving population. Tier II provides comprehensive results of drugs associated with potential impairment.